Evidence map›Paper›PMID 28904225›Full record

ArticleScience translational medicine2017

Endothelial APLNR regulates tissue fatty acid uptake and is essential for apelin's glucose-lowering effects.

Cheol Hwangbo, Jingxia Wu, Irinna Papangeli, Takaomi Adachi, Bikram Sharma, Saejeong Park, Lina Zhao, Hyekyung Ju, Gwang-Woong Go, Guoliang Cui and 10 more

Abstract read
In one paragraph

Article in Science translational medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 87 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. The Apelinergic System in Kidney Disease: Novel Perspectives.International journal of molecular sciences · 2025
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Silencing APLNR enhances the radiosensitivity of prostate cancer by modulating the PI3K/AKT/mTOR signaling pathway.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 1 country.

Cheol HwangboYale Cardiovascular Research Center, Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT 06511, USA.ORCID http://orcid.org/0000-0001-6505-3080
Jingxia WuYale Cardiovascular Research Center, Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT 06511, USA.ORCID http://orcid.org/0000-0002-7573-4741
Irinna PapangeliYale Cardiovascular Research Center, Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT 06511, USA.ORCID http://orcid.org/0000-0002-3151-4237
Takaomi AdachiYale Cardiovascular Research Center, Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT 06511, USA.ORCID http://orcid.org/0000-0003-3160-1872
Bikram SharmaDepartment of Biology, Stanford University, Stanford, CA 94304, USA.
Saejeong ParkYale Cardiovascular Research Center, Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT 06511, USA.
Lina ZhaoYale Cardiovascular Research Center, Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT 06511, USA.
Hyekyung JuYale Cardiovascular Research Center, Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT 06511, USA.
Gwang-Woong GoYale Cardiovascular Research Center, Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT 06511, USA.ORCID http://orcid.org/0000-0002-3848-8705
Guoliang CuiDepartment of Immunobiology, Yale School of Medicine, New Haven, CT 06511, USA.ORCID http://orcid.org/0000-0001-5559-7957
Mohammed InayathullahBiomaterials and Advanced Drug Delivery Laboratory, Stanford University, Stanford, CA 94304, USA.ORCID http://orcid.org/0000-0001-7646-1709
Judith K JobBiomaterials and Advanced Drug Delivery Laboratory, Stanford University, Stanford, CA 94304, USA.ORCID http://orcid.org/0000-0002-2393-5613
Jayakumar RajadasBiomaterials and Advanced Drug Delivery Laboratory, Stanford University, Stanford, CA 94304, USA.
Stephanie L KweiSection of Plastic and Reconstructive Surgery, Yale School of Medicine, New Haven, CT 06511, USA.
Ming O LiImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.ORCID http://orcid.org/0000-0002-1383-0535
Alan R MorrisonYale Cardiovascular Research Center, Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT 06511, USA.ORCID http://orcid.org/0000-0002-2412-7669
Thomas QuertermousDivision of Cardiovascular Medicine, Stanford University, Stanford, CA 94304, USA.ORCID http://orcid.org/0000-0002-7645-9067
Arya ManiYale Cardiovascular Research Center, Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT 06511, USA.ORCID http://orcid.org/0000-0001-6699-259X
Kristy Red-HorseDepartment of Biology, Stanford University, Stanford, CA 94304, USA.
Hyung J ChunYale Cardiovascular Research Center, Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT 06511, USA. hyung.chun@yale.edu.ORCID http://orcid.org/0000-0003-3508-2678
Yale University · USStanford University · USCardiovascular Institute of the South · USMemorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Uncoupling of IL-1 beta and VEGF-A Crosstalk Contributes to Impaired Arteriogenesis Response to Ischemia in Chronic Diabetes MellitusP20GM103652 · NIGMS · OCEAN STATE RESEARCH INSTITUTE, INC. · PI ROUNDS, SHARON IRENE SMITH · 2013 to 2022
$21.3M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
The Identification and characterization of genetic variants underlying cardiovascular diseasesR35HL135767 · NHLBI · YALE UNIVERSITY · PI MANI, ARYA · 2017 to 2023
$7.0M
Vanderbilt Mouse Metabolic Phenotyping CenterU2CDK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2016 to 2021
$6.3M
Mechanotransduction and transcriptional regulation during artery developmentR01HL128503 · NHLBI · STANFORD UNIVERSITY · PI Mary Red-Horse · 2015 to 2026
$5.8M
Nutrient Sensing and mTORC1 Signaling in the Control of Regulatory T Cell Generation and FunctionR01AI102888 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI LI, MING · 2014 to 2022
$4.3M
Role of MicroRNAs 424 and 503 in Pulmonary Arterial HypertensionR01HL113005 · NHLBI · YALE UNIVERSITY · PI CHUN, HYUNG JOON · 2012 to 2016
$2.0M
Investigation of genetic and physiological causes of inherited Vascular and MetabR01HL094784 · NHLBI · YALE UNIVERSITY · PI MANI, ARYA · 2009 to 2013
$2.0M
Yale Cardiovascular Center faculty recruitmentP30HL101284 · NHLBI · YALE UNIVERSITY · PI SIMONS, MICHAEL · 2009 to 2010
$1.2M
Role of Apelin in the Systemic and Pulmonary VasculatureK08HL095654 · NHLBI · YALE UNIVERSITY · PI CHUN, HYUNG JOON · 2009 to 2013
$668k
BLRD VA IK2 BX002527NCATS NIH HHS UL1 TR001863NCI NIH HHS P30 CA008748NHLBI NIH HHS K08 HL095654NHLBI NIH HHS P30 HL101284NHLBI NIH HHS R01 HL094784NHLBI NIH HHS R01 HL113005NHLBI NIH HHS R01 HL128503NHLBI NIH HHS R35 HL135767NIAID NIH HHS R01 AI102888NIDDK NIH HHS U24 DK059637NIDDK NIH HHS U2C DK059637NIGMS NIH HHS P20 GM103652
6 · The paper itself

Abstract

Treatment of type 2 diabetes mellitus continues to pose an important clinical challenge, with most existing therapies lacking demonstrable ability to improve cardiovascular outcomes. The atheroprotective peptide apelin (APLN) enhances glucose utilization and improves insulin sensitivity. However, the mechanism of these effects remains poorly defined. We demonstrate that the expression of APLNR (APJ/AGTRL1), the only known receptor for apelin, is predominantly restricted to the endothelial cells (ECs) of multiple adult metabolic organs, including skeletal muscle and adipose tissue. Conditional endothelial-specific deletion of

Indexed as

AgingAnimalsApelinApelin ReceptorsEndotheliumFatty Acid-Binding ProteinsFatty AcidsForkhead Box Protein O1GlucoseHumansHuman Umbilical Vein Endothelial CellsMaleMice, KnockoutSignal TransductionApelinApelin ReceptorsFabp4 protein, mouseFatty Acid-Binding ProteinsFatty AcidsForkhead Box Protein O1Foxo1 protein, mouseGlucose

Identifiers

PMID28904225
PMCPMC5703224
OpenAlexW2754411658

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.